Alzheimer's disease: Ageing-related or age-related? New hypotheses from an old debate

Neurological Sciences

Volumn 32, Issue 6, 2011, Pages 1241-1247

  Bugiani, Orso ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Age; Ageing; Alzheimer's disease; Beta protein; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALLOCORTEX; ALZHEIMER DISEASE; ARTICLE; CELL SELECTION; ENZYME ACTIVITY; HUMAN; INCIDENCE; NEOCORTEX; NERVOUS SYSTEM DEVELOPMENT; PATHOGENESIS; PREVALENCE; PROTEIN FUNCTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; NEUROFIBRILLARY TANGLES;

EID: 84856211280     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0614-4     Document Type: Article

References (84)

1. Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9:1118-1127
2. Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA (2001) Copernicus revisited: Amyloid beta in Alzheimer's disease. Neurobiol Aging 22:131-146 (Pubitemid 32333008)
3. Pallas M, Camins A, Smith MA, Perry G, Lee HG, Casadesus G (2008) From aging to Alzheimer's disease: Unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 15:615-624
4. Zhu X, Lee HG, Perry G, Smith MA (2007) Alzheimer disease, the two-hit hypothesis: An update. Biochim Biophys Acta 1772:494-502 (Pubitemid 46400383)
5. Wolfe MS, Guénette SY (2007) APP at a glance. J Cell Sci 120:3157-3161 (Pubitemid 350018406)
6. Wang DS, Dickson DW, Malter JS (2006) Beta-amyloid degradation and Alzheimer's disease. J Biomed Biotechnol 2006: 58406
7. Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A betadeposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800 (Pubitemid 34663580)
8. Alafuzoff I, Thal DR, Arzberger T et al (2009) Assessment of beta-amyloid deposits in human brain: A study of the BrainNet Europe Consortium. Acta Neuropathol 117:309-320
9. Bugiani O, Giaccone G, Frangione B, Ghetti B, Tagliavini F (1989) Alzheimer patients: Preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system. Neurosci Lett 103:263-268 (Pubitemid 19214399)
10. Klunk WE, Price JC, Mathis CA et al (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27:6174-6184 (Pubitemid 46890033)
11. Bu G, Cam J, Zerbinatti C (2006) LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci 1086:35-53
12. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12:383-388
13. Hardy J (2006) Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr Alzheimer Res 3:71-73
14. Cappai R, Barnham KJ (2008) Delineating the mechanism of Alzheimer's disease: A beta peptide neurotoxicity. Neurochem Res 33:526-532 (Pubitemid 351230455)
15. Small DH, Mok SS, Bornstein JC (2001) Alzheimer's disease and Abeta toxicity: From top to bottom. Nat Rev Neurosci 2:595-598 (Pubitemid 33679833)
16. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99:6364-6369
17. Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995) Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879-888
18. Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S (2002) Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115:201-211 (Pubitemid 35232701)
19. Samura E, Shoji M, Kawarabayashi T et al (2006) Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1. Brain Res 1094:192-199 (Pubitemid 43927605)
20. Lewis J, Dickson DW, Lin WL et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487-1491 (Pubitemid 32801551)
21. Götz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced bu Abeta42 fibrils. Science 293:1491-1495 (Pubitemid 32807681)
22. Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321-332 (Pubitemid 39061125)
23. Huang HC, Jiang ZF (2009) Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: Relationship and links in Alzheimer's disease. J Alzheimers Dis 16:15-27
24. Galvan V, Gorostiza OF, Banwait S et al (2006) Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 103:7130-7135
25. Giaccone G, Pedrotti B, Migheli A et al (1996) betaPP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. Am J Pathol 148:79-87 (Pubitemid 26019646)
26. Barbato C, Canu N, Zambrano N et al (2005) Interaction of Tau with Fe65 links tau to APP. Neurobiol Dis 18:399-408 (Pubitemid 40431124)
27. Müller T, Concannon CG, Ward MW et al (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell 18:201-210 (Pubitemid 46066721)
28. Ebly EM, Parhad IM, Hogan DB, Fung TS (1994) Prevalence and types of dementia in the very old: Results from the Canadian Study of Health and Aging. Neurology 44:1593-1600 (Pubitemid 24286631)
29. Fichter MM, Meller I, Schröppel H, Steinkirchner R (1995) Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidity. Br J Psychiatry 166: 621-629
30. Prencipe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F (1996) Prevalence of dementia in an elderly rural population: Effects of age, sex, and education. J Neurol Neurosurg Psychiatry 60:628-633 (Pubitemid 26237113)
31. Jorm AF, Jolley D (1998) The incidence of dementia. A metaanalysis. Neurology 51:728-733
32. von Strauss E, Viitanen M, De Ronchi D, Winblad B, Fratiglioni L (1999) Aging and the occurrence of dementia. Findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 56:587-592 (Pubitemid 29218154)
33. Braak H, Braak E (1991) Neuropathological staging of Alzheimer- related changes. Acta Neuropathol 82:239-259
34. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404 (Pubitemid 44469160)
35. Götz J, Schonrock N, Vissel B, Ittner LM (2009) Alzheimer's disease selective vulnerability and modeling in transgenic mice. J Alzheimers Dis 18:243-251
36. Hardy J (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159 (Pubitemid 27116286)
37. Cork LC (1990) Neuropathology of Down syndrome and Alzheimer disease. Am J Med Genet Suppl 7:282-286
38. Rovelet-Lecrux A, Hannequin D, Raux G et al (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24-26 (Pubitemid 43011878)
39. Rogaeva E, Meng Y, Lee JH et al (2007) The neuronal sortilinrelated receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39:168-177 (Pubitemid 46184347)
40. Carter DB (2005) The interaction of amyloid-beta with ApoE. Subcell Biochem 38:255-272
41. van Es MA, van den Berg LH (2009) Alzheimer's disease beyond APOE. Nat Genet 41:1047-1048
42. Scheuner D, Eckman C, Jensen M et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:864-870 (Pubitemid 26296755)
43. Liao MQ, Tzeng YJ, Chang LY et al (2007) The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett 581:1161-1165 (Pubitemid 46394550)
44. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267-298 (Pubitemid 37064935)
45. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101-112 (Pubitemid 46432529)
46. McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46:860-866
47. Wang J, Dickson DW, Trojanowski JQ et al (1999) The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol 158:328-337 (Pubitemid 29382824)
48. Tabaton M, Piccini A (2005) Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease. Int J Exp Pathol 86:139-145 (Pubitemid 40813910)
49. Lu DC, Rabizadeh S, Chandra S et al (2000) A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 6:397-404 (Pubitemid 30208156)
50. Di Fede G, Catania M, Morbin M et al (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323:1473-1477
51. Ritchie K, Kildea D (1995) Is senile dementia "age-related" or "ageing-related"? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 346:931-934
52. Ritchie K, Kildea D, Robine JM (1992) The relationship between age and the prevalence of senile dementia: A meta-analysis of recent data. Int J Epidemiol 21:763-769
53. Wernicke TF, Reischies FM (1994) Prevalence of dementia in old age: Clinical diagnoses in subjects aged 95 years and older. Neurology 44:250-253 (Pubitemid 24070961)
54. Mizutani T, Shimada H (1992) Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 108:168-177
55. Samuelsson SM, Alfredson BB, Hagberg B et al (1997) The Swedish Centenarian Study: A multidisciplinary study of five consecutive cohorts at the age of 100. Int J Aging Hum Dev 45:223-253 (Pubitemid 28044747)
56. Itoh Y, Yamada M, Suematsu N, Matsushita M, Otomo E (1998) An immunohistochemical study of centenarian brains: A comparison. J Neurol Sci 157:73-81 (Pubitemid 28179539)
57. Silver MH, Newell K, Brady C, Hedley-White ET, Perls TT (2002) Distinguishing between neurodegenerative disease and disease-free aging: Correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med 64:493-501 (Pubitemid 34556415)
58. Coppus A, Evenhuis H, Verberne GJ et al (2006) Dementia and mortality in persons with Down's syndrome. J Intellect Disabil Res 50:768-777 (Pubitemid 44336413)
59. Head E, Lott IT, Patterson D, Doran E, Haier RJ (2007) Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: Targets for nonpharmacological intervention. J Alzheimers Dis 11:61-76 (Pubitemid 46376710)
60. Katzman R, Terry R, DeTeresa R et al (1998) Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138-144
61. Bennett DA, Schneider JA, Arvanitakis Z et al (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837-1844 (Pubitemid 44049813)
62. Lee JH (2003) Genetic evidence for cognitive reserve: Variations in memory and related cognitive functions. J Clin Exp Neuropsychol 25:594-613 (Pubitemid 36808146)
63. Bugiani O, Giaccone G, Rossi G et al (2010) Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 67:987-995
64. Crook R, Verkkoniemi A, Perez-Tur J et al (1998) A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 4:452-455 (Pubitemid 28212762)
65. Alladi S, Xuereb J, Bak T et al (2007) Focal cortical presentations of Alzheimer's disease. Brain 130:2636-2645 (Pubitemid 47511719)
66. Rabinovici CD, Jagust WJ, Furst AJ et al (2008) Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64:388-401
67. Bruni AC, Bernardi L, Colao R et al (2010) Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation. Neurology 74:798-806
68. Marcon G, Giaccone G, Cupidi C et al (2004) Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol 63:199-209 (Pubitemid 38327940)
69. Kemp PM, Holmes C, Hoffmann SM et al (2003) Alzheimer's disease: Differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 74:715-719 (Pubitemid 36628280)
70. Götz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9:532-544 (Pubitemid 351873467)
71. Di Maria E, Cammarata S, Parodi MI et al (2010) The H1 haplotype of the Tau gene (MAPT) is associated with mild cognitive impairment. J Alzheimers Dis 19:909-914
72. Myers AJ, Kaleem M, Marlowe L et al (2005) The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet 14:2399-2404 (Pubitemid 41418001)
73. Myers AJ, Pittman AM, Zhao AS et al (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25:561-570
74. Ginsberg SD, Che S, Counts SE, Mufson EJ (2006) Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Neurochem 96:1401-1408
75. Terry RD (1996) The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 55:1023-1025 (Pubitemid 26338013)
76. Arendt T (2005) Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging 21:783-796
77. Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (2005) Cognitive impairment in preclinical Alzheimer's disease: A metaanalysis. Neuropsychology 19:520-531 (Pubitemid 41077134)
78. Jin K, Peel AL, Mao XO et al (2004) Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 101:343-347 (Pubitemid 38084252)
79. Li B, Yamamori H, Tatebayashi Y et al (2008) Failure of neuronal maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol 67:78-84
80. Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, Hyslop PS, Bernstein A (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev 13:2801-2810
81. Porayette P, Gallego MJ, Kaltcheva MM, Vadakkadath Meethal S, Atwood CS (2009) Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J Biol Chem 284:23806-23817
82. Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, Selkoe DJ (2007) A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci 27:14459-14469
83. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981-989
84. Spreafico R, Arcelli P, Frassoni C et al (1999) Development of layer I of the human cerebral cortex after midgestation: Architectonic findings, immunocytochemical identification of neurons and glia, and in situ labeling of apoptotic cells. J Comp Neurol 410:126-142 (Pubitemid 29284225)